REMI (Remedent) Cyclically Adjusted PB Ratio: (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

REMI Remedent Inc REMI
12 GF Score
Price $0.00
View Full Analysis

What is Remedent Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Remedent  (OTCPK:REMI) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Remedent Cyclically Adjusted PB Ratio Related Terms


Remedent Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Remedent's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Remedent Cyclically Adjusted PB Ratio Chart

Remedent Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Remedent Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

REMI vs SECI, RSCF, OZSC: Cyclically Adjusted PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, Remedent's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Remedent Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Remedent's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Remedent's Cyclically Adjusted PB Ratio falls into.


REMI
12GF Score
Remedent Inc REMI
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Remedent Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Remedent's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2020 is calculated as:

For example, Remedent's adjusted Book Value per Share data for the three months ended in Dec. 2020 was:

Adj_Book=Book Value per Share/CPI of Dec. 2020 (Change)*Current CPI (Dec. 2020)
=0.228/108.5107*108.5107
=0.228

Current CPI (Dec. 2020) = 108.5107.

Remedent Quarterly Data

Book Value per Share CPI Adj_Book
201103 0.114 94.666 0.131
201106 0.096 95.508 0.109
201109 0.068 95.795 0.077
201112 0.016 96.360 0.018
201203 0.094 97.847 0.104
201206 0.047 97.659 0.052
201209 0.051 98.432 0.056
201212 0.029 98.511 0.032
201303 0.073 98.937 0.080
201306 0.076 99.215 0.083
201309 0.076 99.314 0.083
201312 0.085 99.462 0.093
201403 0.116 99.819 0.126
201406 0.118 99.482 0.129
201409 0.119 99.195 0.130
201412 0.121 99.086 0.133
201503 0.105 99.423 0.115
201506 0.113 100.107 0.122
201509 0.115 100.245 0.124
201512 0.115 100.572 0.124
201603 0.109 101.653 0.116
201606 0.113 102.267 0.120
201609 0.115 102.118 0.122
201612 0.118 102.614 0.125
201703 0.155 103.972 0.162
201706 0.158 103.902 0.165
201709 0.162 104.170 0.169
201712 0.165 104.804 0.171
201803 0.162 105.419 0.167
201806 0.155 106.063 0.159
201809 0.151 106.618 0.154
201812 0.141 107.252 0.143
201903 0.270 107.876 0.272
201906 0.258 107.896 0.259
201909 0.253 107.470 0.255
201912 0.245 108.065 0.246
202003 0.227 108.550 0.227
202006 0.226 108.540 0.226
202009 0.224 108.441 0.224
202012 0.228 108.511 0.228

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Remedent Business Description

Address Zuiderlaan 1-3, Bus 8, Ghent, BEL, 9000
Remedent Inc is a manufacturer of cosmetic dentistry products in Europe. The company is engaged in the research, development, and manufacturing of oral care and cosmetic dentistry products. It designs, develops, manufactures, and distributes cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, the Middle East, and the United States.
12GF Score

Get the complete analysis for REMI

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price